Francesca Cicchetti

Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Mutant huntingtin in the extracellular matrix: A new perspective on Huntington's disease pathology.

Mutant huntingtin in the extracellular matrix: A new perspective on Huntington's disease pathology.

Journal: Neurobiology of disease

Published: May 04, 2026

WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease.

WDR44 drives de novo α-synuclein aggregation at the lysosomal membrane and promotes neuronal dysfunction in Parkinson's Disease.

Journal: bioRxiv : the preprint server for biology

Published: April 17, 2026

Parkinson's Disease-vulnerable and -resilient dopamine neurons display opposite responses to excitatory input.

Parkinson's Disease-vulnerable and -resilient dopamine neurons display opposite responses to excitatory input.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2025

The impact of tau deletion on Huntington's disease: An in vivo perspective.

The impact of tau deletion on Huntington's disease: An in vivo perspective.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 21, 2025

Restoring brain barriers: an innovative approach for treating neurological disorders.

Restoring brain barriers: an innovative approach for treating neurological disorders.

Journal: Fluids and barriers of the CNS

Published: May 20, 2025

Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.

Tau levels in platelets isolated from Huntington's disease patients serve as a biomarker of disease severity.

Journal: Journal of neurology

Published: December 23, 2024

Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson's disease-like neurodegeneration.

Erythrocyte-derived extracellular vesicles transcytose across the blood-brain barrier to induce Parkinson's disease-like neurodegeneration.

Journal: Fluids and barriers of the CNS

Published: December 15, 2024

Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.

Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models.

Journal: Neurobiology of disease

Published: June 19, 2024

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington's disease cases.

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington's disease cases.

Journal: Neurobiology of disease

Published: February 26, 2024

Corrigendum to "Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease" [Neurobiology of Disease, 2024 Jan:190:106376].

Corrigendum to "Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease" [Neurobiology of Disease, 2024 Jan:190:106376].

Journal: Neurobiology of disease

Published: February 24, 2024

Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseases.

Healthy blood, healthy brain: a window into understanding and treating neurodegenerative diseases.

Journal: Journal of neurology

Published: January 26, 2024

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease.

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease.

Journal: Neurobiology of disease

Published: October 02, 2023

Showing 1-12 of 91

Last Updated: 09/26/2026